DNMR - Danimer Scientific, Inc.
NYSE
->
Basic Materials
->
Specialty Chemicals
Bainbridge,
United States
Type: Equity
DNMR price evolution
DNMR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $54.42 | $71.58 | $73.5 | |
| Short term investments | ||||
| Net receivables | $16.25 | $11.51 | $12.91 | $15.88 |
| Inventory | $26.04 | $26.28 | $25.99 | $25.27 |
| Total current assets | $69.87 | $86.87 | $104.77 | $108.04 |
| Long term investments | $31.45 | $31.45 | $31.45 | |
| Property, plant & equipment | $449.39 | $453.42 | $459 | $464.31 |
| Goodwill & intangible assets | $76.42 | $77.17 | $77.79 | |
| Total noncurrent assets | $579.67 | $584.16 | $590.09 | |
| Total investments | $31.45 | $31.45 | $31.45 | |
| Total assets | $643.77 | $666.54 | $688.92 | $698.13 |
| Current liabilities | ||||
| Accounts payable | $4.54 | $2.88 | $3.88 | $5.29 |
| Deferred revenue | $0.85 | $1.15 | $1 | |
| Short long term debt | $10.7 | $4.51 | $4.71 | |
| Total current liabilities | $21.33 | $19.21 | $16.03 | $15.72 |
| Long term debt | $381.87 | $408.37 | $405.73 | $403.36 |
| Total noncurrent liabilities | $413.3 | $416.8 | $404.39 | |
| Total debt | $419.07 | $410.24 | $408.07 | |
| Total liabilities | $432.18 | $432.51 | $432.83 | $420.11 |
| Shareholders' equity | ||||
| Retained earnings | -$525.88 | -$504.05 | -$481.38 | -$454.12 |
| Other shareholder equity | ||||
| Total shareholder equity | $234.03 | $256.09 | $278.02 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $73.5 | $64.4 | $286.97 | $379.9 |
| Short term investments | ||||
| Net receivables | $15.88 | $19.62 | $20.98 | $6.61 |
| Inventory | $25.27 | $32.74 | $24.57 | $13.64 |
| Total current assets | $108.04 | $125.07 | $340.36 | $402.38 |
| Long term investments | $31.45 | $31.45 | $13.41 | $13.41 |
| Property, plant & equipment | $464.31 | $472.98 | $335.42 | $126.18 |
| Goodwill & intangible assets | $77.79 | $80.94 | $147.31 | $1.8 |
| Total noncurrent assets | $590.09 | $587.2 | $498.24 | $143.82 |
| Total investments | $31.45 | $31.45 | $13.41 | $13.41 |
| Total assets | $698.13 | $712.27 | $838.6 | $546.2 |
| Current liabilities | ||||
| Accounts payable | $5.29 | $14.98 | $20.79 | $10.61 |
| Deferred revenue | $1 | $0.21 | $2.46 | |
| Short long term debt | $4.71 | $5.31 | $3.69 | $28.2 |
| Total current liabilities | $15.72 | $25.29 | $43.48 | $50.49 |
| Long term debt | $403.36 | $308.51 | $283.63 | $55.56 |
| Total noncurrent liabilities | $404.39 | $309.37 | $294.86 | $139.67 |
| Total debt | $408.07 | $313.82 | $287.32 | $83.76 |
| Total liabilities | $420.11 | $334.66 | $338.33 | $190.16 |
| Shareholders' equity | ||||
| Retained earnings | -$454.12 | -$298.65 | -$118.89 | -$58.78 |
| Other shareholder equity | ||||
| Total shareholder equity | $278.02 | $377.61 | $500.26 | $356.04 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8.63 | $7.63 | $10.22 | $10.95 |
| Cost of revenue | $14.53 | $16.54 | $17.32 | |
| Gross Profit | -$6.56 | -$6.9 | -$6.31 | -$6.37 |
| Operating activities | ||||
| Research & development | $5.11 | $5.34 | $7.58 | |
| Selling, general & administrative | $6.75 | $6.87 | $16.89 | |
| Total operating expenses | $12.2 | $12.43 | $12.21 | $24.66 |
| Operating income | -$19.33 | -$18.52 | -$31.03 | |
| Income from continuing operations | ||||
| EBIT | -$13.59 | -$18.42 | -$30.92 | |
| Income tax expense | $0 | $0 | $0 | $0 |
| Interest expense | -$9.84 | $9.07 | $8.84 | $8.51 |
| Net income | ||||
| Net income | -$21.84 | -$22.66 | -$27.26 | -$39.43 |
| Income (for common shares) | -$22.66 | -$27.26 | -$39.43 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $46.68 | $53.22 | $58.75 | $47.33 |
| Cost of revenue | $73.64 | $63.63 | $57.87 | $35.88 |
| Gross Profit | -$26.96 | -$10.41 | $0.88 | $11.46 |
| Operating activities | ||||
| Research & development | $29.24 | $31.94 | $20.27 | $7.85 |
| Selling, general & administrative | $68.98 | $81.59 | $80 | $19.34 |
| Total operating expenses | $98.66 | $177.02 | $100.36 | $27.18 |
| Operating income | -$125.62 | -$187.43 | -$99.47 | -$15.73 |
| Income from continuing operations | ||||
| EBIT | -$125.51 | -$178.84 | -$72.58 | -$6.43 |
| Income tax expense | $0.32 | -$0.81 | -$13.23 | |
| Interest expense | $29.64 | $1.72 | $0.76 | $2.43 |
| Net income | ||||
| Net income | -$155.47 | -$179.76 | -$60.11 | -$8.85 |
| Income (for common shares) | -$155.47 | -$179.76 | -$60.11 | -$8.85 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$22.66 | -$27.26 | -$39.43 | |
| Operating activities | ||||
| Depreciation | $7.4 | $7.49 | $7.33 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.59 | $0.57 | $13.81 | |
| Total cash flows from operations | -$18.97 | -$12.99 | -$15.93 | |
| Investing activities | ||||
| Capital expenditures | -$1.8 | -$1.97 | -$1.96 | |
| Investments | ||||
| Total cash flows from investing | -$6.32 | -$1.8 | -$1.97 | -$1.96 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.01 | $13.65 | $0.22 | |
| Net borrowings | $3.61 | -$0.61 | -$0.59 | |
| Total cash flows from financing | $15.58 | $3.61 | $13.04 | -$0.46 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$37.2 | -$17.16 | -$1.92 | -$18.35 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$155.47 | -$179.76 | -$60.11 | -$8.85 |
| Operating activities | ||||
| Depreciation | $29.06 | $20.09 | $10.63 | $5.12 |
| Business acquisitions & disposals | -$0.01 | -$151.18 | ||
| Stock-based compensation | $56.03 | $56.96 | $55.27 | $3.65 |
| Total cash flows from operations | -$47.26 | -$61.84 | -$62.96 | -$13.8 |
| Investing activities | ||||
| Capital expenditures | -$27.66 | -$164.43 | -$184.99 | -$38.26 |
| Investments | -$18.04 | |||
| Total cash flows from investing | -$27.66 | -$182.48 | -$336.17 | -$38.26 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.51 | $0.36 | $140.31 | $420.2 |
| Net borrowings | $83.67 | $21.61 | $202.66 | $2.47 |
| Total cash flows from financing | $84.03 | $21.75 | $306.2 | $422.68 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $9.1 | -$222.57 | -$92.93 | $370.62 |
News
Fundamentals
| Market cap | $1.06M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 3.02M |
| Revenue | $37.43M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$111.20M |
| Revenue Q/Q | -21.17% |
| Revenue Y/Y | -26.70% |
| P/E ratio | -0.01 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.03 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$36.83 |
|---|---|
| ROA | -16.49% |
| ROE | N/A |
| Debt/Equity | 1.51 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.28 |
| Quick ratio | 2.05 |